Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Price Agreement Rate Was 46.8% with Med. Institutions as of July
November 6, 2006
- Recommendation Grades of Drugs to Treat Osteoporosis Included in 2006 GL
November 6, 2006
- 24 New Drugs Approved
November 6, 2006
- R&DNEWS IN BRIEF
November 6, 2006
- SEMINAR
November 6, 2006
- OPINION
November 6, 2006
- MD Devices, Diagnostics at Chuikyo
November 6, 2006
- NEW PRODUCTS
November 6, 2006
- MEDICAL DEVICE NEWS IN BRIEF
November 6, 2006
- Signa HDe, BrightSpeed Granted Good Design Awards: GE Yokogawa Medical System
November 6, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 6, 2006
- Call for Withdrawal from JPA Gathers Momentum among JACDS Members
November 6, 2006
- SEMINAR
November 6, 2006
- 4 Domestic Companies to File for Pre-pandemic Flu Vaccine in 2007
October 30, 2006
- REGULATORY NEWS IN BRIEF
October 30, 2006
- 21st Scientific Meeting of the International Society of Hypertension (ISH2006)
October 30, 2006
- METI to Investigate Needs for R&D Promotion Taxation System
October 30, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 30, 2006
- R&D NEWS IN BRIEF
October 30, 2006
- Korosho to Repeat Survey to Eliminate "Provisional Delivery"
October 30, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…